調査レポートカテゴリー： MarketsandMarkets, 世界, 医療/バイオ

High Throughput Screening (HTS) Market by Technology (Cell Based, Ultra High Throughput Screening (uHTS), Label Free, Bioinformatics), by Apllications (Target Identification, Primary Screening, Toxicology, Stem Cell) & by End Users (Pharmaceutical Industry, Biotechnology Industry, CRO) - Forecast to 2018

世界のハイスループットスクリーニング（高速大量スクリーニング）市場動向及び予測（～2018）

◆タイトル：High Throughput Screening (HTS) Market by Technology (Cell Based, Ultra High Throughput Screening (uHTS), Label Free, Bioinformatics), by Apllications (Target Identification, Primary Screening, Toxicology, Stem Cell) & by End Users (Pharmaceutical Industry, Biotechnology Industry, CRO) - Forecast to 2018
◆商品コード：BT 2220
◆調査・発行会社：MarketsandMarkets
◆発行日：2014年2月
◆ページ数：248
◆レポート形式：pdf / 英語
◆納品方法：Eメール
◆調査対象地域：グローバル
◆販売価格オプション（消費税別）
Single userUSD5,650 ⇒換算￥615,850見積依頼/購入/質問フォーム
Multi User（～5名）USD6,650 ⇒換算￥724,850見積依頼/購入/質問フォーム
Corporate licence（社内共有可） USD8,150 ⇒換算￥888,350見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※商品の納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。（振込先：三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。（但し、対応範囲は弊社で判断）
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

 【レポートの概要】

本調査レポートでは、"世界のハイスループットスクリーニング（高速大量スクリーニング）市場動向及び予測（～2018）"について調査・分析し、イントロダクション、エグゼクティブサマリー、プレミアムインサイト、市場概観、市場の機会と課題、バリューチェーン分析、市場環境分析、市場の動態、技術別分析、用途別分析、地域別分析、市場規模及び予測、競争状況、新製品発売、主要企業（ベンダー）分析等の情報をお届けいたします。

“Technological Advancements and Flourishing Outsourcing Industry Likely to Propel the Growth of the Global High Throughput Screening (HTS) Market”

In this report, the global high throughput screening (HTS) market has been segmented on the basis of technology, products, applications, end users, and geography. The label-free technology market is expected to grow at the highest CAGR of 11.1% from 2013 to 2018. This technology offers the direct detection ability, which was not possible with cell-based assays. Moreover, this technology helps in the reduction of drug failure rate due to toxicity and is applicable for a majority of drug classes.

In the HTS applications market, the target identification segment accounted for the largest share in 2013. The large share of this segment can be attributed to factors such as the availability of large compound libraries, presence of well-equipped HTS laboratories, and technological advancements. Large pharmaceutical and biotechnology companies are investing heavily in automation of HTS laboratories and are also entering into strategic partnerships and collaborations with research institutes, thereby leading to efficient utilization of HTS in varied application fields. However, the primary screening segment of the HTS market is estimated to register the highest growth rate. This can be attributed to the availability of a large number of potential lead compounds, emergence of several new detection technologies, and availability of novel primary and stem cell phenotypes. The HTS market by end users is broadly categorized into pharmaceutical companies, biotechnology companies, academic and government institutes, contract research organizations (CROs), and others. The pharmaceuticals segment dominated the market with a market share of around 48% in 2013.

The global HTS market is in its growth phase and is poised to cross the $19 billion mark by 2018. The factors responsible for the growth of this market include technological innovations, open innovation models adopted by pharmaceutical companies, increasing drug discovery initiatives by academic institutions, and huge capital investments in the HTS technology by organizations. Moreover, the presence of a large untapped market in emerging countries and growth in outsourcing of drug discovery services especially in China and India are the various growth opportunities for this market.

Over the next five years, Asia is expected to grow at the highest CAGR of 9.1%. Factors such as growth in investments as well as the growth in the outsourcing industry, and favorable economic conditions are responsible for the high growth of the HTS market in Asia.

This research report covers a detailed analysis of various aspects of the HTS market, including the views on emerging and high-growth segments of HTS, emerging technologies, and high-growth regions. The report also discusses the drivers, restraints, opportunities, and the competitive landscape including key players in the HTS market along with their product portfolios, developments, and the strategies adopted by these players to maintain and grow their market shares in the near future. The above mentioned market research data, current market size, and the forecast of future trends will help established players and new entrants to make the necessary strategic decisions regarding investments in product development and market development and/or diversification. This data would also help companies to plan their product offerings, geographic focus, strategic approach, and R&D investments for innovation in their products and technologies and levels of output, in order to gain a competitive edge.

【レポートの目次】

Table Of Contents

1 Introduction (Page No. – 19)
1.1 Objectives of The Study
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Market Scope
1.6 Research Methodology
1.6.1 Secondary Sources
1.6.2 Primary Sources
1.6.3 Market Size Estimation
1.6.4 Market Share
1.6.5 Key Data Points From Secondary Sources
1.6.6 Key Data Points From Primary Sources
1.6.7 Assumptions

2 Executive Summary (Page No. – 36)

3 Premium Insights (Page No. – 40)
3.1 HTS Market – A Sub-Segment of Drug Discovery Market
3.2 Global HTS Market
3.3 Market Dynamics
3.4 Geographic Analysis & HTS Technologies Market
3.5 Technology Market
3.6 End-User Analysis
3.7 Competitive Analysis

4 Market Overview (Page No. – 47)
4.1 Introduction
4.2 Technology Evolution
4.3 Market Segmentation
4.4 Market Dynamics
4.4.1 Drivers
4.4.1.1 Adoption of Open Innovation Models By Pharmaceutical Companies to Increase The Use of HTS
4.4.1.2 Increasing Drug Discovery Initiatives By Academic and Government Institutions to Boost The Demand for HTS Products
4.4.1.3 Increasing Capital Investments in HTS Technology By Organizations Lead to The Growth of HTS
4.4.1.4 Technological Advancements in Research Leading to Large Potential Candidates for Screening Will Help HTS
4.4.1.5 Increase in The Number of Outsourced Drug Discovery Services Will Propel The HTS Market
4.4.2 Restraints
4.4.2.1 The Capital-Intensive Nature of HTS Will Hamper The Growth of This Market
4.4.2.2 Assay Development for HTS Becoming Difficult for New Target Classes
4.4.3 Opportunities
4.4.3.1 Growing Asian Market to Boost The HTS Market
4.4.3.2 High Throughput Cellular Microarrays Increasingly Being Used in toxicology and Stem Cell Research, Thus Prompting Its Growth
4.4.3.3 Growth of Contract Research Organizations (Cros) in Emerging Countries to Bolster The HTS Market
4.4.3.4 Label-Free Technology Emerging As A Valuable Tool for Drug Discovery
4.5 Trends
4.5.1 Label-Free Method Gaining Importance in HTS Labs
4.5.2 HTS Techniques Increasingly Being Used in The Field of Toxicology
4.5.3 Automation & Miniaturization of HTS Techniques
4.6 Strategic Benchmarking
4.6.1 New Product Launches
4.6.1.1 Agilent Technologies Introduced The Rapidfire 365 High Throughput Mass Spectrometry System
4.6.1.2 Perkinelmer Introduced The Janus Biotx Pro Automated Workstation
4.6.1.3 Beckman Coulter Introduced The Navios Flow Cytometry System
4.6.1.4 Sigma-Aldrich Introduced The Compozr Transporter Knockout Human Cell Lines in Plate format
4.6.1.5 Tecan Group Introduced Dako Omnis
4.6.2 Technology Integration
4.6.2.1 Collaboration Between Agilent & Baylor College of Medicine’s Medical Genetics Laboratories
4.6.2.2 Collaboration Between Perkinelmer & The National Center for Drug Screening (Ncds)
4.6.2.3 Partnership of Beckman Coulter With Illumina
4.6.2.4 Agreement of Sigma-Aldrich Corporation With Alphagenix
4.6.2.5 Agreement of Tecan Group With Tap Biosystems
4.7 Value Chain Analysis
4.8 Porter’s Five Forces Analysis
4.8.1 Threat From New Entrants
4.8.2 Threat From Substitutes
4.8.3 Bargaining Power of Buyers
4.8.4 Bargaining Power of Suppliers
4.8.5 Competitive Rivalry Among Existing Players
4.9 Key Player Analysis

5 By Technology (Page No. – 72)
5.1 Introduction
5.2 Cell-Based Assays
5.2.1 Cell-Based Assays Are Used in More Than 50% of HTS Assays
5.3 Ultra High Throughput Screening (UHTS)
5.3.1 UHTS Increasers The Number of Potential Drug Candidates Tested Per Day
5.4 Lab-On-A-Chip (Loac)
5.4.1 Loac Market to Grow At A High Pace
5.5 Label-Free Technology
5.5.1 Label-Free Technology to Grow At The Fastest Pace in HTS Market
5.6 Bioinformatics
5.6.1 Bioinformatics Reduces The Cost and Duration of Drug Discovery Process

6 By Product (Page No. – 83)
6.1 Introduction
6.2 Instruments
6.2.1 The Demand for Automated and Easy-to-Use Systems On A Rise
6.3 Consumables/Reagents
6.3.1 Assay Kits to Drive The HTS Market
6.4 Software & Services
6.4.1 Outsourcing to Drive The HTS Services Market

7 By Application (Page No. – 91)
7.1 Introduction
7.2 Target Identification
7.2.1 Target Identification Segment Occupies The Largest Share of HTS Applications Market
7.3 Primary Screening
7.3.1 Primary Screening is The Second Largest HTS Applications Market
7.4 Toxicology
7.4.1 Recent Advancements Present Significant Opportunities for Toxicity Testing
7.5 Stem Cell Biology
7.5.1 Stem Cells Provide Significant Advantages to HTS Technology
7.6 Other Applications

8 By End Users (Page No. – 102)
8.1 Introduction
8.2 Pharmaceutical & Biotechnology Industry
8.2.1 Pharmaceutical Companies Are The Biggest End-Users for HTS
8.3 Academic & Government Institutes
8.3.1 Open Innovation to Drive The HTS Market in Government Sector
8.4 Contract Research Organizations (Cro)
8.4.1 Emerging Countries to Drive The HTS Market for Cro
8.5 Other Industries (Hospitals/Clinics, Agriculture, Environmental Labs)

9 Geographic Analysis (Page No. – 113)
9.1 Introduction
9.2 North America
9.2.1 Rising Investments By Drug Discovery Companies to Drive The North American HTS Market
9.2.2 Collaborations Between Companies and Academic Institutes On A Rise
9.3 Europe
9.3.1 Public-Private Partnerships to Goad The European HTS Market
9.4 Asia
9.4.1 Government Initiatives Provide Scope for Growth of HTS Market in Asia
9.5 Rest of The World (ROW)

10 Competitive Landscape (Page No. – 161)
10.1 Introduction
10.1.1 New Product Launch, The Key Growth Strategy Adopted By HTS Players
10.1.2 New Product Launch
10.1.3 Agreements, Partnerships, and Collaborations
10.1.4 Mergers & Acquisitions
10.1.5 Expansions
10.1.6 Other Developments

11 Company Profiles (Overview, Financials, Products & Services, Strategy, & Developments)* (Page No. – 170)
11.1 Agilent Technologies, Inc.
11.2 Aurora Biomed
11.3 Axxam Spa
11.4 Beckman Coulter, Inc. (A Subsidiary of Danaher)
11.5 Bio-Rad Laboratories
11.6 Biofocus Dpi Ltd.
11.7 Intellicyt Corporation
11.8 Luminex Corporation
11.9 Perkinelmer, Inc.
11.10 Sigma Aldrich Corporation
11.11 Tecan Group Ltd.
11.12 Thermo Fisher Scientific, Inc.

*Details on Financials, Product & Services, Strategy, & Developments Might Not Be Captured in Case of Unlisted Companies.

Appendix (Page No. – 232)

List of Tables (75 Tables)

Table 1 Global High Throughput Screening Market, By Technology, 2011-2018 ($Million)
Table 2 HTS Market, By Technology, 2011-2018 ($Million)
Table 3 Cell-Based Assays Market, By Geography, 2011-2018 ($Million)
Table 4 Ultra High Throughput Screening Market, By Geography, 2011-2018 ($Million)
Table 5 Lab-on-A-Chip Market, By Geography, 2011-2018 ($Million)
Table 6 Label-Free Technology Market, By Geography, 2011-2018 ($Million)
Table 7 Bioinformatics Market, By Geography, 2011-2018 ($Million)
Table 8 HTS Market, By Product,2011-2018 ($Million)
Table 9 HTS Instruments Market, By Geography, 2011-2018 ($Million)
Table 10 HTS Consumables/Reagents Market, By Geography, 2011-2018 ($Million)
Table 11 HTS Software & Services Market, By Geography, 2011-2018 ($Million)
Table 12 HTS Market, By Application, 2011-2018 ($Million)
Table 13 HTS Target Identification Market, By Geography, 2011-2018 ($Million)
Table 14 HTS Primary Screening Market, By Geography, 2011-2018 ($Million)
Table 15 HTS Toxicology Market, By Geography, 2011-2018 ($Million)
Table 16 HTS Stem Cell Biology Market, By Geography, 2011-2018 ($Million)
Table 17 HTS Other Applications Market, By Geography, 2011-2018 ($Million)
Table 18 Global Market Revenue, By End User, 2011-2018 ($Million)
Table 19 Pharmaceutical: HTS Market, By Geography, 2011-2018 ($Million)
Table 20 Biotechnology: HTS Market, By Geography, 2011-2018 ($Million)
Table 21 Academic & Government: HTS Market, By Geography, 2011-2018 ($Million)
Table 22 Contract Research Organization: HTS Market, By Geography, 2011-2018 ($Million)
Table 23 Other Industries: HTS Market, By Geography, 2011-2018 ($Million)
Table 24 Global High Throughput Screening Market Revenue, By Geography, 2011-2018 ($Million)
Table 25 North America: Market, By Technology, 2011-2018 ($Million)
Table 26 North America: Cell-Based Assays Market, By End User, 2011-2018 ($Million)
Table 27 North America: Ultra High Throughput Screening Market, By End User, 2011-2018 ($Million)
Table 28 North America: Lab-on-A-Chip Market, By End User, 2011-2018 ($Million)
Table 29 North America: Label-Free Technology Market, By End User, 2011-2018 ($Million)
Table 30 North America: Market, By Product, 2011-2018 ($Million)
Table 31 North America: Cell-Based Assays Market, By Product, 2011-2018 ($Million)
Table 32 North America: Ultra High Throughput Screening Market, By Product, 2011-2018 ($Million)
Table 33 North America: Lab-on-A-Chip Market, By Product, 2011-2018 ($Million)
Table 34 North America: Label-Free Technology Market, By Product, 2011-2018 ($Million)
Table 35 North America: Market, By Application, 2011-2018 ($Million)
Table 36 North America: Market, By End User, 2011-2018 ($Million)
Table 37 Europe: Market, By Technology, 2011-2018 ($Million)
Table 38 Europe: Ultra High Throughput Screening Market, By End User, 2011-2018 ($Million)
Table 39 Europe: Cell-Based Assays Market, By End User, 2011-2018 ($Million)
Table 40 Europe: Lab-on-A-Chip Market, By End User, 2011-2018 ($Million)
Table 41 Europe: Label-Free Technology Market, By End User, 2011-2018 ($Million)
Table 42 Europe: Market, By Product, 2011-2018 ($Million)
Table 43 Europe: Cell-Based Assays Market, By Product, 2011-2018 ($Million)
Table 44 Europe: Ultra High Throughput Screening Market, By Product, 2011-2018 ($Million)
Table 45 Europe: Lab-on-A-Chip Market, By Product, 2011-2018 ($Million)
Table 46 Europe: Label-Free Technology Market, By Product, 2011-2018 ($Million)
Table 47 Europe: Market, By Application, 2011-2018 ($Million)
Table 48 Europe: Market, By End User, 2011-2018 ($Million)
Table 49 Asia: Market, By Technology, 2011-2018 ($Million)
Table 50 Asia: Cell-Based Assays Market, By End User, 2011-2018 ($Million)
Table 51 Asia: Ultra High Throughput Screening Market, By End User, 2011-2018 ($Million)
Table 52 Asia: Lab-on-A-Chip Market, By End User, 2011-2018 ($Million)
Table 53 Asia: Label-Free Technology Market, By End User, 2011-2018 ($Million)
Table 54 Asia: Market, By Product, 2011-2018 ($Million)
Table 55 Asia: Cell-Based Assays Market, By Product, 2011-2018 ($Million)
Table 56 Asia: Ultra High Throughput Screening Market, By Product, 2011-2018 ($Million)
Table 57 Asia: Lab-on-A-Chip Market, By Product, 2011-2018 ($Million)
Table 58 Asia: Label-Free Technology Market, By Product, 2011-2018 ($Million)
Table 59 Asia: Market, By Application, 2011-2018 ($Million)
Table 60 Asia: Market, By End User, 2011-2018 ($Million)
Table 61 ROW: Market, By Technology, 2011-2018 ($Million)
Table 62 ROW: Cell-Based Assays Market, By End User, 2011-2018 ($Million)
Table 63 ROW: Ultra High Throughput Screening Market, By End User, 2011-2018 ($Million)
Table 64 ROW: Lab-on-A-Chip Market, By End User, 2011-2018 ($Million)
Table 65 ROW: Label-Free Technology Market, By End User, 2011-2018 ($Million)
Table 66 ROW: Market, By Product, 2011-2018 ($Million)
Table 67 ROW: Cell-Based Assays Market, By Product, 2011-2018 ($Million)
Table 68 ROW: Ultra High Throughput Screening Market, By Product, 2011-2018 ($Million)
Table 69 ROW: Lab-on-A-Chip Market, By Product, 2011-2018 ($Million)
Table 70 ROW: Label-Free Technology Market, By Product, 2011-2018 ($Million)
Table 71 ROW: Market, By Application, 2011-2018 ($Million)
Table 72 ROW: Market, By End User, 2011-2018 ($Million)
Table 73 Other Mergers & Acquisitions (2011-2013)
Table 74 Other Agreements & Collaborations (2011-2013)
Table 75 Other Product Launch (2011-2013)

List of Figures (23 Figures)

Figure 1 Research Methodology for The High Throughput Screening Market
Figure 2 Market Size Estimation Methodology for The High Throughput Screening Market
Figure 3 Forecast Model
Figure 4 Data Triangulation Methodology (3600 Evaluation)
Figure 5 Global Market Revenue, By Geography, 2011-2018 ($Million)
Figure 6 HTS Share in Overall Drug Discovery Market (2013)
Figure 7 Global HTS Market, 2011 - 2018 ($Million) & Growth Rate
Figure 8 Market Dynamics for HTS
Figure 9 HTS Technologies Market, By Geography (2013)
Figure 10 Opportunity Matrix: HTS Technology Market (2013-2018)
Figure 11 HTS Market, By End-User, 2013 ($Million)
Figure 12 HTS Market Key Players: Geographic Reach Vs Product Portfolio (2013)
Figure 13 High Throughput Screening Technology Evolution
Figure 14 HTS Market Segmentation
Figure 15 New Product Launches
Figure 16 Technology Integration
Figure 17 Value Chain - Drug Discovery Process
Figure 18 Value Chain Analysis - High Throughput Screening Instruments
Figure 19 Porter’s Five Forces Analysis
Figure 20 HTS Market, By Technology, 2013 ($Million)
Figure 21 Global HTS Market, By End User, 2013 Vs.2018
Figure 22 Global HTS Market, Growth Phase, By Geography
Figure 23 Key Growth Strategies in The HTS Market, 2011-2013

★調査レポート[世界のハイスループットスクリーニング（高速大量スクリーニング）市場動向及び予測（～2018）] ( High Throughput Screening (HTS) Market by Technology (Cell Based, Ultra High Throughput Screening (uHTS), Label Free, Bioinformatics), by Apllications (Target Identification, Primary Screening, Toxicology, Stem Cell) & by End Users (Pharmaceutical Industry, Biotechnology Industry, CRO) - Forecast to 2018 / BT 2220) 販売に関する免責事項
[世界のハイスループットスクリーニング（高速大量スクリーニング）市場動向及び予測（～2018）] ( High Throughput Screening (HTS) Market by Technology (Cell Based, Ultra High Throughput Screening (uHTS), Label Free, Bioinformatics), by Apllications (Target Identification, Primary Screening, Toxicology, Stem Cell) & by End Users (Pharmaceutical Industry, Biotechnology Industry, CRO) - Forecast to 2018 / BT 2220) についてEメールでお問い合わせ
◆関連調査資料◆
  • ハイスループットスクリーニング（HTS）の世界市場予測（～2023年）：細胞アッセイ、Lab-on-a-chip、バイオインフォマティクス
    BT2220 / MarketsandMarkets / 2018年4月24日 / 当調査レポートでは、ハイスループットスクリーニング（HTS）の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、技術（細胞アッセイ、Lab-on-a-chip、バイオインフォマティクス）別分析、用途別分析、製品別分析、需要先別分析、ハイスループットスクリーニング（HTS）の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global high-throughput screening (HTS) market is projected to reach USD 21.69 Billion by 2023 from USD 14.87 Billion in 2018, at a CAGR of 7.8%. The major factors driving the growth of the HTS market include initiatives undertaken by pharmaceutical and biotechnology companies, increasing R&D spending, technological advancements in HTS, and the availability of government funding and venture capital investments. The report analyzes the global HTS market by product & service, technology, application, end user, and region. On the basis of product & service, the reagents & assay kits segment accounted for the largest share of the global HTS...
  • 薬物スクリーニング検査の世界市場予測（～2022年）：免疫測定アナライザー、クロマトグラフィー、飲酒検知器、迅速検査デバイス、アッセイキット
    MD-3239 / MarketsandMarkets / 2018年1月15日 / MarketsandMarketsが発行した当調査レポートでは、薬物スクリーニング検査の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、製品別分析、サービス別分析、サンプル種類別分析、需要先別分析、薬物スクリーニング検査の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...“Global drug screening market projected to grow at a CAGR of 10.2% during the forecast period”The drug screening market is expected to reach USD 8.63 billion million by 2022 from USD 5.32 billion in 2017, at a CAGR of 10.2%. Growing drug & alcohol consumption, enforcement of stringent laws mandating drug and alcohol testing, and the presence of government funding in major markets are factors driving the growth of the drug screening market. On the other hand, market growth may be limited to a certain extent due to the prohibition of workplace drug testing in some countries and the ban...
  • ラベルフリー検出の世界市場予測（～2022年）：技術（表面プラズモン共鳴法、バイオレイヤー干渉法）、製品、用途、エンドユーザー
    BT-2455 / MarketsandMarkets / 2017年10月11日 / MarketsandMarketsが発行した当調査レポートでは、ラベルフリー検出の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、技術別分析、製品別分析、用途別分析、需要先別分析、ラベルフリー検出の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global label-free detection market is expected to reach USD 1,311.2 Million by 2022 from USD 872.0 Million in 2017, at a CAGR of 8.5%. A number of factors such as increasing number of genomics research activities for studying diseases, advances in label-free detection techniques, growing awareness and demand for use of biosensors in biomolecular interaction studies, and increasing expenditure on drug discovery and development by private and public organizations are expected to drive the growth of this market. The global label-free detection market is segmented by product, technology, application, end user, and region. By product, the market is segmented...
  • 3D細胞培養の世界市場予測（～2022年）：足場材フリー（懸滴培養、バイオリアクタ）、マイクロ流体力学、磁気浮上
    MAM-BT-4414 / MarketsandMarkets / 2017年11月8日 / MarketsandMarketsが発行した当調査レポートでは、3D細胞培養の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品種類別分析、用途別分析、需要先別分析、地域別分析、3D細胞培養の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global 3D cell culture market is projected to reach USD 1,720.3 Million by 2022 from USD 682.8 Million in 2017, at a CAGR of 20.3%. Factors such as rising focus on developing alternative methods for animal testing, funding initiatives from government and private investors, technological advancements and product launches, and growing awareness are driving the growth of the market. The report segments the global market into by type of product, application, end user, and region. Based on product, the market is segmented into scaffold-based 3D cell culture, scaffold-free 3D cell culture, microfluidics-based 3D cell culture, and magnetic levitation and...
  • 試験管内肺モデルの世界市場予測（～2023年）
    BT6203 / MarketsandMarkets / 2018年4月25日 / MarketsandMarketsが発行した当調査レポートでは、試験管内肺モデルの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、種類（2D、3D）別分析、用途別分析、地域別分析、試験管内肺モデルの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The lung in vitro models market is projected to reach USD 427.4 Million by 2023 from USD 190.5 Million in 2018, at a CAGR of 17.5%. The key factors driving the growth of this market include growing focus on developing alternatives for animal testing models, advancements in cell culture technologies, and the development of new 3D in vitro models. The report analyzes the lung in vitro models market by type, applications, and region. Based on type, the in vitro lung model market is segmented into 2D cell models and 3D cell models. 3D cell models is further segmented into in-house...
  • セルラー集団検診（健診）の世界市場予測（～2022年）
    MAM-BT5413 / MarketsandMarkets / 2017年7月14日 / 当調査レポートでは、セルラー集団検診（健診）の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、種類別分析、サンプル別分析、健診場所別分析、地域別分析、セルラー集団検診（健診）の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global cellular health screening market is expected to reach USD 3.42 Billion by 2022 from USD 2.12 Billion in 2017, at a CAGR of 10.0% during the forecast period. A number of factors such as increasing adoption of telomere performance programs for leading a healthy life; growing importance of healthy life expectancy (HALE); rising government focus towards preventive healthcare; rising geriatric population and resultant growth in the need for cellular health screening; increasing research activities; growing adoption of the direct-to-consumer approach; and the increasing burden of chronic diseases are driving the demand for global cellular health screening. On the...
  • 細胞アッセイの世界市場予測（～2022年）：試薬、アッセイキット、マイクロプレート、細胞株、サービス
    MAM-BT2486 / MarketsandMarkets / 2017年7月6日 / 当調査レポートでは、細胞アッセイの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品別分析、用途別分析、需要先別分析、地域別分析、細胞アッセイの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global cell-based assays market is expected to reach USD 19.92 Billion by 2022 from USD 13.34 Billion in 2017, at a CAGR of 8.4%. A number of factors, such as growing funding and investments in R&D, the increasing prevalence of chronic disorders, increase in drug discovery activities, and the advantages of cell-based assays over alternative technologies are expected to drive the growth of this market. The global market is segmented by product, application, end user, and region. By product, the global market is segmented into consumables, instruments, service and software. The consumables segment is expected to lead the global...
  • 創薬インフォマティクス（情報科学）の世界市場予測（～2022年）
    MAM-HIT-5838 / MarketsandMarkets / 2017年12月18日 / MarketsandMarketsが発行した当調査レポートでは、創薬インフォマティクス（情報科学）の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、機能別分析、ソリューション別分析、需要先別分析、地域別分析、創薬インフォマティクス（情報科学）の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...“The global drug discovery informatics market is projected to grow at a CAGR of 11.2%.”The global drug discovery informatics market is expected to reach USD 2.84 billion in 2022 from USD 1.67 billion in 2017 at a CAGR of 11.2%. Growth in the drug discovery informatics market is mainly driven by factors such as rising R&D expenditure across the globe, increasing focus on drug delivery, and the need to control drug discovery and development costs. Impending patent expiries and the growing biotechnology industry are also expected to provide a wide range of growth opportunities for players in the market. On...

    • ◆H&Iグローバルリサーチ株式会社のお客様（例）◆